Gleevec's Rapid Rise To Blockbuster Status

In the 25 years since FDA implemented the landmark Orphan Drug Act, providing incentives to drug makers to develop drugs for rare diseases, the area of drug development has largely been left to nimble biotechs and specialty pharmas

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet